Search Results - "Rizkala, A.R"

Reduced cognitive function is associated with poor outcomes in HFpEF: a post hoc analysis from PARAGON-HF by Dewan, P, Jhund, P.S, Anand, I.S, Desai, A.S, Pieske, B, Rizkala, A.R, Shah, S.J, Shi, V.C, Van Veldhuisen, D.J, Zannad, F, Zile, M.R, Solomon, S.D, McMurray, J.J.V

“…Abstract Background Little is known about the prevalence and consequences of cognitive impairment in patients with heart failure and preserved ejection…”
Get full text

Effect of sacubitril/valsartan on cognitive function in patients with HFpEF: a prespecified analysis of PARAGON-HF by Dewan, P, Jhund, P.S, Anand, I.S, Desai, A.S, Gong, J, Lefkowitz, M.P, Pieske, B, Rizkala, A.R, Shah, S.J, Van Veldhuisen, D.J, Zannad, F, Zile, M.R, Solomon, S.D, McMurray, J.J.V

“…Abstract Background A theoretical concern has been raised about detrimental effects of sacubitril/valsartan (sac/val) on cognitive function as neprilysin is…”
Get full text

Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation by Singh, A.K., Coyne, D.W., Shapiro, W., Rizkala, A.R., the DRIVE Study Group

“…Treating hemodialysis patients to combat anemia corrects hemoglobin but exacerbates iron deficiency by utilizing iron stores. Patients needing iron should…”
Get full text

Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease by Agarwal, R., Rizkala, A.R., Kaskas, M.O., Minasian, R., Trout, J.R.

“…Non-dextran intravenous (i.v.) iron preparations seem to differentially affect proteinuria in patients with chronic kidney disease. To study effects of ferric…”
Get full text

Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients by Sirken, G, Raja, R, Rizkala, A R

“…In vitro evidence suggests that different intravenous iron (i.v. Fe) preparations may be associated with different infection rates. This observational study…”
Get more information